Form 4: Kenvue Inc. Executive Caroline Tillett Reports Stock Transactions
SEC Form 4 Filing
Chief Scientific Officer Caroline Tillett reports the vesting of restricted stock units and subsequent tax withholding.
Summary
- On March 5, 2025, Caroline Tillett, Chief Scientific Officer of Kenvue Inc., reported transactions involving Kenvue's common stock.
- Tillett vested 4,267.56 restricted stock units (RSUs) which converted into common stock.
- 1,529 shares were withheld for payment of taxes at a price of $23.04 per share.
- Following these transactions, Tillett directly owns 44,128.76 shares of Kenvue common stock and 8,533.13 restricted stock units.
- The RSUs vest in three equal installments on March 5, 2025, March 5, 2026, and March 5, 2027, contingent upon continued service.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions, and carries a neutral sentiment.
Industry Context
This filing is a routine disclosure of insider transactions, which are common for executives receiving stock-based compensation. It provides transparency into the ownership stake of company leadership.
Stakeholder Impact
- The filing provides transparency to shareholders regarding executive compensation and ownership.
Key Dates
| Date | Description |
|---|---|
| 03/05/2025 | Date of earliest transaction: Vesting of restricted stock units and tax withholding. |
| 03/05/2025 | First vesting date of restricted stock units. |
| 03/05/2026 | Second vesting date of restricted stock units. |
| 03/05/2027 | Third vesting date of restricted stock units. |
| 03/07/2025 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.